May 9 |
Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
|
May 8 |
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
|
May 8 |
Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript
|
May 8 |
Teva hits a five-year high on schizophrenia trial win, Q1 beat
|
May 8 |
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
May 8 |
Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter
|
May 8 |
Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation
|
May 8 |
UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue risea
|
May 8 |
Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
|
May 8 |
Teva Pharm Q1 profit misses estimates, revenue risea
|